Client of a consultant lobbyist
Emergent BioSolutions Canada Inc.
- Meetings this Parliament
- 7
- With MPs
- 1
- Since Nov 2021
- 7
- Active registrations
- 1
Most recent reported meeting: Aug 20, 2026.
Lobbying by Emergent BioSolutions Canada Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Aug 8, 2026
Consultant Jodee Mason of Counsel Public Affairs Inc.
Consultant lobbyists
- Jodee Mason
Institutions they may lobby: Correctional Service of Canada (CSC), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), National Defence (DND), Prairies Economic Development Canada (PrairiesCan), Prime Minister's Office (PMO), Public Health Agency of Canada (PHAC), Public Safety Canada (PS), Public Services and Procurement Canada (PSPC), Royal Canadian Mounted Police (RCMP), Senate of Canada, Veterans Affairs Canada (VAC)
What they're lobbying on (8)Hide details
- Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
- Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats.
- Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
- To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
- Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
- Discuss changes to take home naloxone program.
- Eligibility for Scientific Research and Experimental Development tax incentives.
- Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
Registration 960841-384311-2. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Jodee Mason · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
-
Reported by Jodee Mason · Consultant
- Paul Eagan · Medical Consultant, National Defence (DND)
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
- Timothy Smith · Deputy Program manager, National Defence (DND)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Jodee Mason · Consultant
- Tim Smith · Deputy Program Manager - Strategic Medical Countermeasures Program, National Defence (DND)
- Natasha Singh · Director, National Defence (DND)
- Amanda Janes · Strategic Planner, Innovation, Science and Economic Development Canada (ISED)
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Jodee Mason · Consultant
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Jodee Mason · Consultant
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Razan Shahin · Sector Analyst, Innovation, Science and Economic Development Canada (ISED)
- Nabeen Abd El Aal · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc · Manager, Innovation, Science and Economic Development Canada (ISED)
and 2 moreShow fewer
- Chris Minaker · Director of Policy, Prairies Economic Development Canada (PrairiesCan)
- Nathalie Leroux · Director General, Prairies Economic Development Canada (PrairiesCan)
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats.
-
Reported by Jodee Mason · Consultant
- Wendy Hepburn · Deputy Director, National Defence (DND)
- Tim Smith · Deputy Program Manager, National Defence (DND)
- Chris Minaker · Director of Policy, Prairies Economic Development Canada (PrairiesCan)
- Paul Eagan · Medical Consultant, National Defence (DND)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Jodee Mason · Consultant
- Doug Eyolfson · Member of Parliament
Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.